Public Relations
Have something to announce? CDL Communications helps secure earned media in the outlets that reach your target audience through a focused PR initiative including:
- Generating publicity by establishing relationships with key media outlets, writing and distributing press releases, and pitching story ideas directly to targeted media
- Planning, coordinating, and promoting webinars and seminars
- Soliciting speaking engagements at appropriate meeting, conferences, and trade shows
Sample Press Releases
Wilson Allen: News
- Bevan Brittan Launches Wilson Proforma Tracker to Streamline Billing Processes and Increase Invoice Accuracy
- Thomson Reuters Elite Expands its Partnership with Wilson Allen to Include 3E Business Development Services
- Perkins Coie Selects Wilson Proforma Tracker to Accelerate and Automate the Client Billing Life Cycle
- eBillingHub and Wilson Allen Announce Partnership and Integration of Wilson Proforma Tracker
- Wilson Allen Introduces the Wilson Template Accelerator Package for Elite 3E
- Wilson Legal Solutions and Stanton Allen to Rebrand As Wilson Allen
- Wilson Legal Solutions and Stanton Allen Ltd. Sign Definitive Merger & Acquisition Agreement
Cloud Pharmaceuticals: News
- Cloud Pharmaceuticals Announces Design of Active Pro-Drug for Treatment of Crohn's Disease and Ulcerative Colitis
- Cloud Pharmaceuticals Announces Partnering Sessions and Presentation Schedule
- Cloud Pharmaceuticals CEO to Discuss Positive Impacts of Digital Disruption on Drug Design at the Cavendish Global Health Impact Forum
- Cloud Pharmaceuticals Appoints Neurological Disorder Expert Jeff Vaught to Its Advisory Board
- Cloud Pharmaceuticals and THERAMetrics Form Strategic Drug Development Collaboration Targeting Orphan CNS Diseases
- Cloud Pharmaceuticals and the University of Florida Department of Medicine Collaborate on the Rapid Design of Novel Cancer Inhibitors
- Cloud Pharmaceuticals and Egenix Form Partnership to Discover New Cancer and Autism Drugs
- Cloud Pharmaceuticals Receives Phase I NSF SBIR Grant Valued at $150,000
- Cloud Pharmaceuticals Announces the In Silico Design of Six New Drugs as Part of Strategic Relationship
- Cloud Pharmaceuticals Granted 1M Hours of Supercomputer Time to Target Orphan Diseases Including Malaria
- Cloud Pharmaceuticals Announces World-Class Board of Directors